Teva-betahistine Tablets: Affected Lots Exceed Or May Exceed The Interim Acceptable Intake Limit For N-nitroso-betahistine.
Teva-Betahistine Tablets are being recalled in Canada because certain batches contain higher levels of N-nitroso-betahistine, a potentially harmful impurity, than what is considered safe for regular use. The affected lots were distributed across Canada. This is classified as a serious safety issue requiring immediate action.
- Product
- TEVA-Betahistine Tablets
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-12-04
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/9f971004-3a5b-425d-b24c-97f13717e0b5